Ken Griffin Medical Devices

Citadel Advisors LLC

$559 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
EW Edwards Lifesciences Corp	$44.3B	$697 Million 0.12% of portfolio	9,418,074	Q4 2024 Added 372.91%
MDT Medtronic PLC	$122B	$477 Million 0.09% of portfolio	5,970,005	Q4 2024 Added 2.56%
BSX Boston Scientific Corp	$149B	$440 Million 0.08% of portfolio	4,931,452	Q4 2024 Reduced 49.64%
ALGN Align Technology Inc	$14.6B	$365 Million 0.07% of portfolio	1,749,826	Q4 2024 Added 12.78%
DXCM Dexcom Inc	$34.1B	$331 Million 0.06% of portfolio	4,261,441	Q4 2024 Added 245.38%
ZBH Zimmer Biomet Holdings, Inc.	$21.9B	$254 Million 0.05% of portfolio	2,406,120	Q4 2024 Added 396.33%
GMED Globus Medical Inc	$6.19B	$213 Million 0.04% of portfolio	2,571,660	Q4 2024 Added 62.08%
PODD Insulet Corp	$18.9B	$190 Million 0.03% of portfolio	729,105	Q4 2024 Reduced 26.39%
GKOS Glaukos Corp	$5.71B	$179 Million 0.03% of portfolio	1,192,739	Q4 2024 Added 231.83%
PEN Penumbra Inc	$10.8B	$174 Million 0.03% of portfolio	734,288	Q4 2024 Added 78.22%
ABT Abbott Laboratories	$242B	$102 Million 0.02% of portfolio	903,000	Q4 2024 Added 149.62%
BRKR Bruker Corp	$7B	$35.5 Million 0.01% of portfolio	605,874	Q4 2024 Added 2,553.04%
RXST Rx Sight, Inc.	$784M	$34.2 Million 0.01% of portfolio	994,167	Q4 2024 Added 369.52%
IRTC I Rhythm Technologies, Inc.	$3.31B	$27.3 Million 0.0% of portfolio	303,056	Q4 2024 Added 450.55%
TMDX Trans Medics Group, Inc.	$2.43B	$14.5 Million 0.0% of portfolio	232,934	Q4 2024 New
NARI Inari Medical, Inc.	$4.27B	$11.8 Million 0.0% of portfolio	231,696	Q4 2024 Added 35.69%
UFPT Ufp Technologies Inc	$1.72B	$11.2 Million 0.0% of portfolio	45,700	Q4 2024 Added 1,210.21%
INSP Inspire Medical Systems, Inc.	$5.34B	$9.72 Million 0.0% of portfolio	52,421	Q4 2024 Reduced 52.48%
LIVN Liva Nova PLC	$2.23B	$7.6 Million 0.0% of portfolio	164,014	Q4 2024 Reduced 74.84%
BFLY Butterfly Network, Inc.	$627M	$6.95 Million 0.0% of portfolio	2,228,619	Q4 2024 Added 150.93%
SYK Stryker Corp	$146B	$6.53 Million 0.0% of portfolio	18,140	Q4 2024 Reduced 52.11%
PRCT Procept Bio Robotics Corp	$2.87B	$5.97 Million 0.0% of portfolio	74,178	Q4 2024 Added 70.07%
TNDM Tandem Diabetes Care Inc	$1.42B	$4.75 Million 0.0% of portfolio	131,826	Q4 2024 Reduced 62.1%
INMD In Mode Ltd.	$1.56B	$4.61 Million 0.0% of portfolio	276,331	Q4 2024 Reduced 12.75%
DCTH Delcath Systems, Inc.	$122M	$3.41 Million 0.0% of portfolio	289,601	Q4 2024 Added 88.1%
VREX Varex Imaging Corp	$513M	$3.31 Million 0.0% of portfolio	226,701	Q4 2024 Reduced 44.9%
SIBN Si Bone, Inc.	$622M	$3.11 Million 0.0% of portfolio	221,692	Q4 2024 Added 90.14%
CERS Cerus Corp	$292M	$2.66 Million 0.0% of portfolio	1,729,505	Q4 2024 Added 62.85%
OFIX Orthofix Medical Inc.	$348M	$2.63 Million 0.0% of portfolio	150,443	Q4 2024 Reduced 47.7%
ITGR Integer Holdings Corp	$4.08B	$2.58 Million 0.0% of portfolio	19,447	Q4 2024 Reduced 52.22%
SNN Smith & Nephew PLC	$12.6B	$2.26 Million 0.0% of portfolio	92,029	Q4 2024 Added 27.44%
NVRO Nevro Corp	$202M	$2.23 Million 0.0% of portfolio	598,852	Q4 2024 Added 11.71%
CNMD Conmed Corp	$1.8B	$1.96 Million 0.0% of portfolio	28,631	Q4 2024 Added 103.1%
TMCI Treace Medical Concepts, Inc.	$495M	$1.95 Million 0.0% of portfolio	261,770	Q4 2024 Added 271.09%
IART Integra Lifesciences Holdings Corp	$1.94B	$1.94 Million 0.0% of portfolio	85,718	Q4 2024 Added 164.46%
QTRX Quanterix Corp	$281M	$1.91 Million 0.0% of portfolio	179,800	Q4 2024 Reduced 3.38%
MXCT Maxcyte, Inc.	$340M	$1.57 Million 0.0% of portfolio	377,598	Q4 2024 Added 646.64%
SRTS Sensus Healthcare, Inc.	$79.1M	$1.35 Million 0.0% of portfolio	197,205	Q4 2024 Added 158.47%
CTKB Cytek Biosciences, Inc.	$604M	$1.31 Million 0.0% of portfolio	201,140	Q4 2024 Reduced 25.66%
KIDS Orthopediatrics Corp	$532M	$1.3 Million 0.0% of portfolio	56,238	Q4 2024 Added 12.25%
AHCO Adapt Health Corp.	$1.53B	$1.3 Million 0.0% of portfolio	136,402	Q4 2024 Reduced 64.09%
ANIK Anika Therapeutics, Inc.	$255M	$1.18 Million 0.0% of portfolio	71,535	Q4 2024 Added 70.04%
STE Steris PLC	$21.9B	$1.07 Million 0.0% of portfolio	5,210	Q4 2024 Added 1,455.22%
PHG Koninklijke Philips Nv	$23B	$1.02 Million 0.0% of portfolio	40,163	Q4 2024 Added 74.08%
ATEC Alphatec Holdings, Inc.	$1.31B	$988,000 0.0% of portfolio	107,669	Q4 2024 Reduced 37.6%
INGN Inogen Inc	$190M	$988,000 0.0% of portfolio	107,829	Q4 2024 Added 37.83%
SGHT Sight Sciences, Inc.	$127M	$914,000 0.0% of portfolio	251,148	Q4 2024 Added 118.96%
SENS Senseonics Holdings, Inc.	$396M	$800,000 0.0% of portfolio	1,540,196	Q4 2024 Added 1,887.91%
MYO Myomo, Inc.	$35.5M	$703,000 0.0% of portfolio	113,391	Q4 2024 New
LUNG Pulmonx Corp	$321M	$688,000 0.0% of portfolio	101,453	Q4 2024 Added 4,312.92%

Shares Options

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Ken Griffin's portfolio

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account